DexCom Execs Sued For Allegedly Misleading Growth Claims

By Sydney Price · April 16, 2025, 8:39 PM EDT

Executives and directors of glucose monitor manufacturer DexCom Inc. have been hit with a derivative suit alleging that they concealed from investors that DexCom struggled to maintain a sales force that...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login